Omega-3 supplements do not improve dry eye symptoms, study finds
Research has shown that, after 12 months, omega-3 supplements provide no benefit in treating dry eye, compared with an olive oil placebo.
There is no evidence for the benefit of omega-3 acid supplementation in treating symptoms of dry eye disease, a study has shown.
Omega-3 fatty acid supplements are often recommended for people with dry eye disease. However, there is no conclusive evidence that they are effective in resolving symptoms.
Researchers carried out a randomised trial involving 349 patients with moderate-to-severe dry eye disease who were assigned to daily 3,000mg omega-3 acid supplementation, compared with 186 patients assigned to olive oil placebo (equivalent to one teaspoon per day).
After 12 months, the researchers found no significant difference between the two groups regarding dry eye disease symptom severity. There was also no difference in secondary outcomes, including corneal damage and tear production.
“We found no evidence of a beneficial effect of n-3 fatty acid supplements as compared with placebo supplements among patients with dry eye disease,” the authors said in the New England Journal of Medicine (3 May 2018).
Citation: Clinical Pharmacist DOI: 10.1211/CP.2018.20204906
Recommended from Pharmaceutical Press
FASTtrack: Pharmacology is a study guide providing an account of drug action, as well as dealing with molecular pharmacology at a more advanced level.£25.00
Introduction to Pharmaceutical Calculations is an essential study aid for pharmacy students. The book contains worked examples and sample questions and answers.£33.00
A comprehensive study guide which summarises the basic principles in pharmacy practice. Clear, bulleted information for quick reference.£43.00
A study aid with 800 MCQs. Assess your knowledge, analytical skills, and ability to apply this knowledge base in clinical practice.£25.00
An introduction to economic evaluation specific to healthcare, for those with little or no knowledge of economics. Covers cost effectiveness, cost utility and cost benefit analysis.£33.00